The effect of metabolic inhibitors on transferrin and iron uptake and transferrin release from reticulocytes.
D000818:Animals; D001151:Arsenic / Q000494:pharmacology; D001386:Azides / Q000494:pharmacology; D001692:Biological Transport / Q000187:drug effects*; D001815:Bloodletting; D002729:Chloromercuribenzoates / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D003864:Depression, Chemical; D004140:Dinitrophenols / Q000494:pharmacology; D004579:Electron Transport / Q000187:drug effects; D005033:Ethylmaleimide / Q000494:pharmacology; D005260:Female; D005459:Fluorides / Q000494:pharmacology; D066298:In Vitro Techniques; D007456:Iodine Isotopes; D007501:Iron / Q000378:metabolism*; D007503:Iron Isotopes; D007854:Lead / Q000494:pharmacology; D008297:Male; D008314:Malonates / Q000494:pharmacology; D009840:Oligomycins / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D011817:Rabbits; D012156:Reticulocytes / Q000378:metabolism*; D012402:Rotenone / Q000494:pharmacology; D014168:Transferrin / Q000378:metabolism*
D001386:Azides; D002729:Chloromercuribenzoates; D003486:Cyanides; D004140:Dinitrophenols; D007456:Iodine Isotopes; D007503:Iron Isotopes; D008314:Malonates; D009840:Oligomycins; D014168:Transferrin; D012402:Rotenone; D007854:Lead; D010042:Ouabain; D003513:Cycloheximide; D007501:Iron; D003545:Cysteine; D001151:Arsenic; D005033:Ethylmaleimide; D005459:Fluorides